Karyopharm therapeutics posts q4 loss per share of $0.76

Karyopharm reports fourth quarter and full year 2019 financial results and highlights recent company progress.q4 loss per share $0.76.q4 earnings per share estimate $-0.67 -- refinitiv ibes data.qtrly total revenues $18.1 million versus $206,000.

KPTI Ratings Summary

KPTI Quant Ranking